Ireland's most popular source of accurate and reliable medicines information
Search 2622 medicines for SPCs, PILs and Educational Materials
COVID-19 Vaccine Information
Latest medicine updates
- Adcetris 50 mg powder for concentrate for solution for infusion Takeda Products Ireland Ltd
Updated - Mekinist 0.5mg and 2mg film-coated tablets Novartis Ireland Limited
Updated - Tafinlar 50mg and 75mg Hard Capsules Novartis Ireland Limited
Updated - Vesitirim 1 mg/ml oral suspension Astellas Pharma Co. Ltd
Updated - HYCAMTIN 1mg and 4mg solution Novartis Ireland Limited
Updated - HYCAMTIN 0.25 mg and 1 mg hard capsules Novartis Ireland Limited
Updated - Mercilon Organon Pharma (Ireland) Limited
Updated
About Medicines.ie
Medicines.ie contains accurate, up to date, regulator approved information on medicines available in Ireland. The site is designed to be a comprehensive and easily searchable source of medicines information in Ireland.
It is widely regarded as an invaluable reference source by healthcare professionals, the National Medicines Information Center and the Department of Health.
The information for each product comes in the form of a Summary of Product Characteristics (SPC or SmPC) and Patient Information Leaflet (PIL) or Package Leaflet (PL), where relevant. These documents are approved by the medicines’ regulator (HPRA or EMA) as part of the process of authorising a medicine for sale or supply in Ireland.
Medicines.ie is continuously updated by pharmaceutical companies when new medicines are launched or the information for an existing medicine changes.
Using Medicines.ie
For information on types of documents on www.medicines.ie, please see below.
Summary of Product Characteristics
Summaries of product characteristics form the basis of information for healthcare professionals on how to use the medicine safely and effectively. Abbreviated as SPC.
Patient Information Leaflet
A PIL is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the SPC.
Educational Materials
EDMs are additional risk minimisation measures that are intended to promote the safe and effective use of the medicine. Educational materials focus on one or more specific safety concerns related to use of the medicine.
XPIL
Some pharmaceutical companies have chosen to display PIL in a HTML text only “Print View” version, called an XPIL, as well as in PDF format. The XPIL is designed for people with sight challenges.